(Q39124523)
Statements
1 reference
Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2). (English)
1 reference
A Kavanaugh
1 reference
J Kremer
1 reference
L Ponce
1 reference
R Cseuz
1 reference
O V Reshetko
1 reference
M Greenwald
1 reference
A Van der Aa
1 reference
F Vanhoutte
1 reference
C Tasset
1 reference
19 December 2016
1 reference
1 reference
76
1 reference
6
1 reference
1009-1019
1 reference
Identifiers
1 reference
1 reference